| Patent Number |
Title Of Patent |
Date Issued |
| 6465506 |
Instillation techniques for ophthalmic agents to enhance treatment effect |
October 15, 2002 |
| The present invention provides methods for instilling an ophthalmic agent. One embodiment of a method according to the invention includes causing a patient to refrain from blinking for at least a specified period of time so as to effect the substantial break down of the patient's tear fi |
| 5435998 |
Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents |
July 25, 1995 |
| Low-tension glaucoma is treated by topical administration to the eye of an amount of a calcium channel blocking agent effective to increase blood flow to the optic nerve head. Calcium channel blocking agents of Class I are especially useful, and among these a preferred agent is verapamil |
| 5431907 |
Treatment of vascular disorders of the posterior segment of the eye by topical administration of |
July 11, 1995 |
| Ischemic disorders of the retina and associated tissues of the posterior segment of the eye are treated by topical administration to the eye of an amount of a calcium channel blocking agent effective to increase blood flow to those tissues. Calcium channel blocking agents of Class I are |
| 4981871 |
Treatment of ocular hypertension with class I calcium channel blocking agents |
January 1, 1991 |
| Elevated intraocular pressure in a mammalian eye is lowered by administering to the eye an amount of a Class I calcium channel blocking agent effective to lower the elevated intraocular pressure. A preferred calcium channel blocking agent is verapamil and the preferred mode of admini |
| 4315024 |
Compositions and method for treating red eye |
February 9, 1982 |
| A method for treating red eye by administering to the afflicted eye a composition comprising an anti-inflammatory amount of an antagonist for H.sub.2 receptors in the eye, preferably cimetidine, and a non-toxic, pharmaceutically acceptable, ophthalmological carrier. |
